LinkedIn Profile

Access Emerge Diagnostics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:emergediagnostics 3011681 May 24th, 2019 12:00AM Emerge Diagnostics Inc. 411 27.00 Open Medical Devices May 24th, 2019 02:11PM May 24th, 2019 02:11PM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Open Electrodiagnostic Functional Assessment (EFA), Soft Tissue Management (STM), Diagnostic Provider Services, Workers'​ Compensation / Risk Management Open 5840 El Camino Real, 102 Carlsbad California US 92008 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 17th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 16th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 15th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 14th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 13th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 12th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 11th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 10th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services
private:emergediagnostics 3011681 Feb 9th, 2018 12:00AM Emerge Diagnostics Inc. 303 16.00 Open Medical Devices Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients. Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5 Emerge Diagnostics Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.